Literature DB >> 21109767

Hyperhomocysteinemia: a renal and cardiovascular risk factor?

Carmine Zoccali, Kitty J Jager.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21109767     DOI： 10.1038/nrneph.2010.142

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  9 in total

1.  B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial.

Authors:  Judith Heinz; Siegfried Kropf; Ute Domröse; Sabine Westphal; Katrin Borucki; Claus Luley; Klaus H Neumann; Jutta Dierkes
Journal:  Circulation       Date:  2010-03-15       Impact factor: 29.690

Review 2.  Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence.

Authors:  David S Wald; Nicholas J Wald; Joan K Morris; Malcolm Law
Journal:  BMJ       Date:  2006-11-25

3.  Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial.

Authors:  Andrew A House; Misha Eliasziw; Daniel C Cattran; David N Churchill; Matthew J Oliver; Adrian Fine; George K Dresser; J David Spence
Journal:  JAMA       Date:  2010-04-28       Impact factor: 56.272

4.  The molecular basis of cystathionine beta-synthase deficiency in Dutch patients with homocystinuria: effect of CBS genotype on biochemical and clinical phenotype and on response to treatment.

Authors:  L A Kluijtmans; G H Boers; J P Kraus; L P van den Heuvel; J R Cruysberg; F J Trijbels; H J Blom
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

Review 5.  Hyperhomocysteinemia and arteriosclerosis: historical perspectives.

Authors:  Kilmer S McCully
Journal:  Clin Chem Lab Med       Date:  2005       Impact factor: 3.694

6.  Homocysteine lowering and cardiovascular events after acute myocardial infarction.

Authors:  Kaare Harald Bønaa; Inger Njølstad; Per Magne Ueland; Henrik Schirmer; Aage Tverdal; Terje Steigen; Harald Wang; Jan Erik Nordrehaug; Egil Arnesen; Knut Rasmussen
Journal:  N Engl J Med       Date:  2006-03-12       Impact factor: 91.245

7.  Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.

Authors:  David S Wald; Malcolm Law; Joan K Morris
Journal:  BMJ       Date:  2002-11-23

8.  Cardiovascular and noncardiovascular mortality among patients starting dialysis.

Authors:  Dinanda J de Jager; Diana C Grootendorst; Kitty J Jager; Paul C van Dijk; Lonneke M J Tomas; David Ansell; Frederic Collart; Patrik Finne; James G Heaf; Johan De Meester; Jack F M Wetzels; Frits R Rosendaal; Friedo W Dekker
Journal:  JAMA       Date:  2009-10-28       Impact factor: 56.272

9.  Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial.

Authors:  Sophia Zoungas; Barry P McGrath; Pauline Branley; Peter G Kerr; Christine Muske; Rory Wolfe; Robert C Atkins; Kathy Nicholls; Margaret Fraenkel; Brian G Hutchison; Robert Walker; John J McNeil
Journal:  J Am Coll Cardiol       Date:  2006-02-23       Impact factor: 24.094
  9 in total
  1 in total

1.  Diagnostic value of the combined measurement of serum hcy, serum cys C, and urinary microalbumin in type 2 diabetes mellitus with early complicating diabetic nephropathy.

Authors:  Tengkai Wang; Qian Wang; Zhimei Wang; Zuomin Xiao; Lunqin Liu
Journal:  ISRN Endocrinol       Date:  2013-09-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.